Table 1 Demographic characteristics of the participants of RBI-4000-101 clinical trial
Cohort 1 | Cohort 2 | Cohort 3 | Cohort 4 | Cohort 5 | Total | |
|---|---|---|---|---|---|---|
RBI-4000 0.1 mcg | RBI-4000 1 mcg | RBI-4000 10 mcg (prime only) | RBI-4000 10 mcg | RabAvert 1 mL | ||
Total—n | 20 | 19 | 19 | 18 | 13 | 89 |
Age (years) | ||||||
Median | 35.5 | 34.0 | 36.0 | 34.0 | 39.0 | 35 |
Range | 23–45 | 25–45 | 22–45 | 20–43 | 27–44 | 20–45 |
Sex—n (%) | ||||||
Male | 10 (50) | 10 (53) | 3 (16) | 8 (44) | 7 (54) | 38 (43) |
Female | 10 (50) | 9 (47) | 16 (84) | 10 (56) | 6 (46) | 51 (57) |
Race—n (%) | ||||||
Black | 5 (25) | 4 (21) | 2 (11) | 4 (22) | 4 (31) | 19 (21) |
White | 15 (75) | 15 (79) | 17 (89) | 12 (67) | 8 (62) | 67 (75) |
Other | 0 (0) | 0 (0) | 0 (0) | 2 (11) | 1 (8) | 3 (3) |
Ethnicity—n (%) | ||||||
Hispanic/Latino | 10 (50) | 9 (47) | 10 (53) | 10 (55) | 6 (46) | 45 (51) |
Other | 10 (50) | 10 (53) | 9 (47) | 8 (45) | 7 (54) | 44 (49) |
